Wesley provides technical input for respiratory and allergic disease development strategy and clinical trial design. Prior to joining PPD in 2012, he served for five years as director of clinical development in respiratory and immuno-inflammation at GlaxoSmithKline with responsibility for designing and coordinating the clinical development of new compounds in respiratory indications, including paediatric populations.
Wesley earned an MBBS (Hons) from University College London Medical School. He trained in general internal medicine and respiratory medicine. He is a member of the Royal College of Physicians and the Faculty of Pharmaceutical Medicine. He holds an active license to practice medicine in the UK with specialist registration (equivalent to board certification) in pharmaceutical medicine.